NASDAQ:PACB

Pacific Biosciences Of California Stock News

Healthcare > Medical - Devices

Buy PACB

*Your capital is at risk

$1.45

-0.180 (-11.04%)

At Close: Jun 05, 2026

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

09:05am, Monday, 05'th May 2025

Collaboration leverages HiFi's unique ability to reveal hidden variants, bringing a new level of precision to early life genetic screening Collaboration leverages HiFi's unique ability to reveal hidde

Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know

07:20pm, Tuesday, 29'th Apr 2025

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.11, marking a -1.77% move from the previous day.

PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

09:05am, Monday, 28'th Apr 2025

Company licenses novel deep learning-based epigenetic models from CUHK enabling the detection of 5hmC, 5mC hemimethylation, and 6mA in standard sequencing runs Company licenses novel deep learning-bas

Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know

07:21pm, Wednesday, 23'rd Apr 2025

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.17, marking no change from the previous day.

Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa

09:05am, Tuesday, 22'nd Apr 2025

International research team aims to develop better understanding of Alzheimer's disease and dementia in diverse populations International research team aims to develop better understanding of Alzheime

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

09:05am, Wednesday, 09'th Apr 2025

Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NE

PacBio Grants Equity Incentive Award to New Employee

07:45pm, Friday, 04'th Apr 2025

MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee

Pacific Biosciences Names Jim Gibson Chief Financial Officer

09:22am, Thursday, 27'th Mar 2025

Pacific Biosciences of California has hired Jim Gibson as its new chief financial officer, effective March 31.

Jim Gibson to join PacBio as Chief Financial Officer

09:05am, Thursday, 27'th Mar 2025

MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be a

Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors

07:20pm, Thursday, 20'th Mar 2025

Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.

Here's Why You Should Retain PacBio Stock in Your Portfolio Now

02:06pm, Thursday, 20'th Mar 2025

PACB continues to deliver growth from its unique technologies amid macroeconomic concerns.

Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

09:05am, Monday, 17'th Mar 2025

MENLO PARK, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Natur

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by